{"gene":"PRKG1","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2013,"finding":"A gain-of-function missense mutation in PRKG1 (p.Arg177Gln) disrupts binding to the high-affinity cGMP binding site within the regulatory domain, rendering PKG-1 constitutively active even in the absence of cGMP. This constitutive activity leads to decreased phosphorylation of the myosin regulatory light chain in fibroblasts, predicted to cause decreased contraction of vascular smooth-muscle cells, and causes familial thoracic aortic aneurysms and acute aortic dissections.","method":"Exome sequencing, Sanger sequencing, functional assay of PKG-1 activity and myosin light chain phosphorylation in patient fibroblasts, LOD score analysis","journal":"American Journal of Human Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic and biochemical validation; constitutive kinase activity demonstrated in patient cells with defined substrate (myosin RLC phosphorylation); replicated in multiple independent families","pmids":["23910461"],"is_preprint":false},{"year":2019,"finding":"PKG1 (PRKG1) phosphorylates TSC2 at S1365 (mouse) / S1364-S1365 (human) in cardiomyocytes and fibroblasts. This phosphorylation activates TSC2's GTPase-activating function toward RHEB, thereby inhibiting stress-stimulated mTORC1 activity without altering basal mTORC1. PKG1-mediated TSC2 phosphorylation is required for PKG1's suppression of hypertrophy and stimulation of autophagy in cardiomyocytes under pressure overload.","method":"In vitro kinase assay, phospho-specific antibodies, homozygous knock-in mice (TSC2-S1365A phosphosilencing and S1365E phosphomimicking), transaortic constriction model, echocardiography, cell culture gain/loss-of-function","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay identifying direct substrate, validated with knock-in mutagenesis in vivo and multiple orthogonal methods in one rigorous study","pmids":["30700906"],"is_preprint":false},{"year":1997,"finding":"PRKG1 is a single-copy gene with 19 exons spanning at least 220 kb that encodes both the type Iα and type Iβ isoforms of cGMP-dependent protein kinase via alternative first exons. The two isoforms differ only in their N-terminal regions, each driven by distinct transcription initiation sites. Several splice sites are conserved with the Drosophila DG2 gene and correlate with boundaries between functional domains of type I cGK.","method":"Gene cloning, 5′-RACE, Northern blot analysis, exon mapping","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cloning and structural characterization with 5′-RACE and Northern blot; single lab but multiple orthogonal molecular methods","pmids":["9192852"],"is_preprint":false},{"year":2016,"finding":"Crystal structure of the PKG Iα regulatory domain bound to cGMP at 2.5 Å reveals that two regulatory domains form a symmetric dimer in which cGMP molecules bound at the high-affinity (B) pockets provide critical inter-subunit contacts. Small-angle X-ray scattering and mutagenesis support the dimer model and indicate the dimer interface modulates kinase activation. The active conformation of PKG is structurally distinct from that of protein kinase A.","method":"X-ray crystallography (2.5 Å), small-angle X-ray scattering (SAXS), site-directed mutagenesis","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution crystal structure combined with SAXS and mutagenesis in a single rigorous study","pmids":["27066748"],"is_preprint":false},{"year":2015,"finding":"cAMP is a partial agonist for PKG Iα. NMR analysis of the cyclic nucleotide-binding domain B shows that cGMP activation follows a two-state conformational selection model, whereas cAMP partial agonism arises from sampling of a third, partially autoinhibited conformational state not accessed by cGMP.","method":"NMR spectroscopy of apo, cGMP-bound, and cAMP-bound forms of PKG cyclic nucleotide-binding domain B; comparative conformational analysis","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR with functional mechanistic interpretation; single lab but rigorous biophysical multi-state analysis","pmids":["26370085"],"is_preprint":false},{"year":2015,"finding":"The N-terminal leucine zipper (LZ) domain of PKG Iα contains C42, which forms an interchain disulfide bond upon oxidation. Crystal structures of wild-type and C42L mutant LZ domains show that the C42–C42′ disulfide bond dramatically stabilizes the PKG Iα dimer, and the C42L mutant mimics the structural conformation of the oxidized wild-type LZ.","method":"X-ray crystallography of wild-type and C42L leucine zipper domains, structural comparison","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures of both WT and mutant with direct structural evidence for disulfide-mediated dimer stabilization","pmids":["26132214"],"is_preprint":false},{"year":2018,"finding":"PKG1α oxidation at C42 (forming a homodimer disulfide) contributes to PDE5 activation and co-localization of PDE5 with PKG1α in stressed cardiomyocytes. Knock-in mice expressing redox-dead PKG1α (C42S) show minimal PDE5 activation after pressure overload and little colocalization of PDE5 with PKG1αC42S, resulting in loss of the antihypertrophic/antifibrotic benefit of PDE5 inhibition (sildenafil) but not sGC stimulation (BAY602770).","method":"Knock-in mouse model (PKG1αC42S), transaortic constriction, PKG activity assay, immunofluorescence co-localization, cardiac phenotyping","journal":"Circulation: Heart Failure","confidence":"High","confidence_rationale":"Tier 2 / Strong — knock-in genetic model with in vivo pressure overload, multiple orthogonal methods (activity assay, co-localization, pharmacological dissection), defining a redox-dependent PKG1α-PDE5 subcellular interaction","pmids":["29545395"],"is_preprint":false},{"year":2011,"finding":"PKG1β (but not PKG1α) forms a trimeric complex with IRAG (inositol trisphosphate receptor-associated cGMP-kinase substrate) and IP3 receptor type I at the endoplasmic reticulum. Phosphorylation of IRAG by PKG1β upon cGMP stimulation reduces IP3-mediated intracellular calcium release, thereby mediating smooth muscle relaxation and inhibition of platelet activation.","method":"Co-immunoprecipitation, isoform-specific interaction mapping, phosphorylation assays, functional studies in smooth muscle and platelets","journal":"American Journal of Physiology: Heart and Circulatory Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP establishing trimeric complex, phosphorylation demonstrated, functional readout in two cell types; review paper summarizing direct experimental data from multiple publications","pmids":["21666108"],"is_preprint":false},{"year":2007,"finding":"PKG-1α mediates inhibition of the store-operated cation channel (SOC/TRPC4) in human glomerular mesangial cells via phosphorylation of VASP at Ser239. PKG-1α-phosphorylated VASP (pSer239-VASP) associates with TRPC4 by co-immunoprecipitation and co-immunostaining, while unphosphorylated VASP does not, demonstrating a phosphorylation-dependent interaction that underlies SOC inhibition.","method":"Fura-2 Ca2+ imaging, RT-PCR, Western blotting, immunocytochemistry, co-immunoprecipitation, specific PKG-1α inhibitor (DT-3), 8-Br-cGMP","journal":"American Journal of Physiology: Renal Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP identifying phosphorylation-dependent VASP–TRPC4 interaction, pharmacological and molecular validation in same study","pmids":["17913834"],"is_preprint":false},{"year":2012,"finding":"Genetic deletion of Prkg1 in mice leads to greater vulnerability to and reduced recovery from noise-induced hearing loss (NIHL). Prkg1 is expressed in cochlear hair cells and neurons and partially overlaps with PDE5 expression. Pharmacological elevation of cGMP by vardenafil (PDE5 inhibitor) almost completely prevented NIHL in a Prkg1-dependent manner, and induced poly(ADP-ribose) (PAR) upregulation in hair cells and spiral ganglion via Prkg1, indicating an endogenous cGMP-Prkg1 protective signaling pathway in the inner ear.","method":"Prkg1 knockout mice, auditory brainstem response measurements, immunohistochemistry for Prkg1 and Pde5, vardenafil treatment, PAR immunostaining","journal":"Nature Medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with defined cellular phenotype, pharmacological rescue with Prkg1-dependent readout, multiple orthogonal methods in one study","pmids":["22270721"],"is_preprint":false},{"year":2010,"finding":"PKG activation in colon cancer cells inhibits TCF-dependent transcription through two mechanisms: (1) transcriptional repression of the CTNNB1 (β-catenin) gene, reducing β-catenin mRNA and protein; and (2) JNK-dependent sequestration of β-catenin by FOXO4, which requires nuclear translocation of FOXO4. FOXO4-specific siRNA completely blocked PKG's inhibitory effect on TCF activity.","method":"Luciferase reporter assays (CTNNB1 and TCF promoters), Western blotting, co-immunoprecipitation (β-catenin/FOXO4), siRNA knockdown, nuclear fractionation","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and siRNA with reporter assays, multiple orthogonal methods in single lab study","pmids":["20348951"],"is_preprint":false},{"year":2007,"finding":"In isolated adult rat cardiomyocytes, NO mobilizes intracellular free Zn2+ via the cGMP/PKG pathway through opening of mitochondrial K(ATP) channels. PKG inhibitor KT5823 blocked Zn2+ release by SNAP, while the PKG activator 8-Br-cGMP mimicked NO action. The released Zn2+ activates ERK, which mediates protection against H2O2-induced loss of mitochondrial membrane potential.","method":"Fluorescence imaging (Newport Green DCF for Zn2+, TMRE for mitochondrial membrane potential), pharmacological inhibitors/activators (KT5823, 8-Br-cGMP, ODQ, NS2028, 5-HD, diazoxide, PD98059), Western blot for ERK phosphorylation","journal":"Cardiovascular Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live-cell imaging with multiple pharmacological probes in primary cardiomyocytes, single lab","pmids":["17570352"],"is_preprint":false},{"year":2015,"finding":"PKG-Iα overexpression in cardiomyocytes and mice induces expression of the H2S-producing enzyme cystathionine-γ-lyase (CSE), increasing H2S levels, without affecting CBS or MPST. Inhibition of CSE by PAG abolishes the cardioprotective effect of PKG-Iα against ischemia/reperfusion injury in vitro and in vivo, indicating H2S is a downstream mediator of PKG-Iα cardioprotection. An inactive kinase-dead mutant (K390A) does not induce CSE, confirming kinase-dependent mechanism.","method":"Adenoviral overexpression of PKGIα and inactive K390A mutant, in vitro ischemia/reperfusion (necrosis/apoptosis assays), in vivo mouse I/R (infarct size, echocardiography), Western blotting for CSE/CBS/MPST, H2S measurement, CSE inhibitor (PAG)","journal":"Basic Research in Cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase-dead mutant controls and CSE inhibitor rescue establish mechanism; single lab but multiple orthogonal in vitro/in vivo methods","pmids":["26036467"],"is_preprint":false},{"year":2019,"finding":"PKG (PRKG1) is required for the anticontractile function of perivascular adipose tissue (PVAT) in mouse resistance arteries. PKG−/− arteries lack PVAT anticontractile function, and DT-2/ODQ inhibition of PKG in PKG+/+ arteries recapitulates this loss. PKG activation by ANP rescues hypoxia-induced loss of PVAT function only in PKG+/+ mice. PKG is also necessary for normal paracrine signaling from adipocytes to smooth muscle and endothelium, and its absence reduces adipocyte adiponectin expression.","method":"Wire myography, PKG−/− mice, adiponectin−/− mice, pharmacological inhibitors (DT-2, ODQ), ANP stimulation, solution transfer experiments","journal":"Cardiovascular Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with defined functional readout, multiple pharmacological and genetic controls in one study","pmids":["24095868"],"is_preprint":false},{"year":2014,"finding":"miR-20a, upregulated by hypoxia in pulmonary artery smooth muscle cells, directly represses PRKG1 expression by targeting two binding sites within the coding region (not the 3′ UTR) of PRKG1 mRNA. Functional studies showed miR-20a promotes PASMC proliferation and migration while inhibiting differentiation, phenocopying loss of PRKG1.","method":"miRNA target site mapping in PRKG1 coding region, miR-20a overexpression/inhibition, cell proliferation/migration assays, hypoxia cell model","journal":"FEBS Letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct mapping of miR-20a binding within PRKG1 coding region with functional rescue; single lab with multiple functional readouts","pmids":["25447536"],"is_preprint":false},{"year":2003,"finding":"PKG-1 expression and activity are approximately two-fold upregulated in the pulmonary vasculature of chronically hypoxic rats, localized specifically to the vasculature by quantitative immunohistochemistry. Despite this upregulation, vasodilatory responses to 8-BrcGMP are attenuated after chronic hypoxia, indicating that the impaired vasodilation is not due to decreased PKG-1 expression/activity.","method":"Isolated perfused lung vasodilatory assay, Western blotting, quantitative immunohistochemistry, PKG activity assay, pharmacological PKG inhibitors (Rp-8-Br-PET-cGMPS, KT-5823)","journal":"American Journal of Physiology: Lung Cellular and Molecular Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional and protein quantification in tissue fractions with pharmacological validation; single lab","pmids":["12765880"],"is_preprint":false},{"year":2024,"finding":"PRKG1 (PKG1) lies downstream of sGC/cGMP signaling and upstream of PINK1 activation. Vericiguat (sGC stimulator) upregulates PRKG1, which activates PINK1 to inhibit mitochondrial dysfunction and mtDNA cytoplasmic leakage, subsequently suppressing the STING/IRF3 inflammatory pathway in doxorubicin-induced cardiotoxicity.","method":"Adeno-associated virus-mediated cardiac PRKG1 manipulation (overexpression/silencing), RNA sequencing pathway analysis, Western blotting for PINK1/STING/IRF3, cardiomyocyte mitochondrial function assays, mouse I/R model","journal":"Translational Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with pathway marker readouts; single lab, multiple methods","pmids":["39059761"],"is_preprint":false},{"year":2019,"finding":"PKG (PRKG1) induces mitochondrial biogenesis in renal proximal tubule cells via a pathway requiring p38 MAPK downstream of PKG. Pharmacological PKG activation (via sGC stimulation) and specific inhibitor studies establish the sequence: sGC → cGMP → PKG → p38 → PGC-1α nuclear localization and phosphorylation.","method":"Pharmacological inhibitors of PKG and p38 in renal proximal tubule cells, in vivo l-skepinone (p38 inhibitor) treatment in mice, nuclear fractionation for phospho-PGC-1α, mitochondrial biogenesis markers","journal":"American Journal of Physiology: Renal Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established with multiple pharmacological probes in vitro and in vivo; single lab","pmids":["31841384"],"is_preprint":false},{"year":2014,"finding":"PKG activity is required for heparin-induced inhibition of vascular smooth muscle cell proliferation. Chemical inhibition of PKG (Rp-8-pCPT-cGMS) and siRNA knockdown of PKG both eliminate heparin effects on BrdU incorporation, ERK activity, Elk-1 phosphorylation, and MKP-1 synthesis. Heparin transiently increases intracellular cGMP, placing PKG downstream of heparin cell-surface receptor engagement.","method":"Chemical PKG inhibitor, PKG siRNA knockdown, BrdU incorporation, ERK/Elk-1 Western blotting, MKP-1 immunoblotting, cGMP ELISA in vascular smooth muscle cells","journal":"Journal of Cellular Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA plus pharmacological inhibition with multiple downstream substrate readouts; single lab","pmids":["24911927"],"is_preprint":false},{"year":2020,"finding":"MASTL-ENSA/ARPP19-PP2A cell cycle checkpoint pathway is present and functional in anucleate human platelets. PKG (activated by cGMP-elevating agents including NO donors and riociguat) phosphorylates ENSA at S109 and ARPP19 at S104, as validated with recombinant PKG and phospho-mutants. These PKG phosphorylation sites are distinct from the MASTL-targeted S67/S62 sites.","method":"Proteomics in human platelets, recombinant MASTL/PKA/PKG kinase assays with recombinant ENSA/ARPP19 and phospho-mutants, pharmacological activation (iloprost, NO donors, riociguat, okadaic acid)","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with recombinant PKG and defined substrates, validated in intact human platelets; single lab","pmids":["32085646"],"is_preprint":false}],"current_model":"PRKG1 encodes cGMP-dependent protein kinase type I (PKG-1), a homodimeric serine/threonine kinase whose N-terminal leucine zipper dimerizes and targets the enzyme via G-kinase-anchoring proteins (including a redox-active C42 disulfide that stabilizes the dimer and localizes the kinase to distinct microdomains); cGMP binding to the high-affinity cyclic nucleotide-binding domain B induces an active dimeric conformation that is structurally distinct from PKA, while cAMP acts as a partial agonist by stabilizing a third partially autoinhibited state; activated PKG-1 phosphorylates a broad substrate network including TSC2 (suppressing stress-stimulated mTORC1), IRAG (reducing ER Ca2+ release via IP3R-I), VASP (modulating cytoskeletal and channel function), and ENSA/ARPP19 (regulating PP2A), thereby controlling vascular smooth muscle relaxation, cardiac hypertrophy, autophagy, platelet inhibition, and inner-ear hair cell survival, with gain-of-function mutations (e.g., p.Arg177Gln) causing constitutive kinase activity and hereditary thoracic aortic aneurysm/dissection."},"narrative":{"mechanistic_narrative":"PRKG1 encodes cGMP-dependent protein kinase type I (PKG-1), a serine/threonine kinase that transduces nitric oxide/cGMP signaling into control of vascular smooth-muscle tone, cardiac remodeling, and cell survival [PMID:23910461, PMID:30700906, PMID:22270721]. The single-copy gene generates Iα and Iβ isoforms through alternative first exons that differ only in their N-terminal regions [PMID:9192852]. Activation is governed by cyclic nucleotide binding to the regulatory domain: crystallography and SAXS show two regulatory domains forming a symmetric dimer in which cGMP bound at the high-affinity B pockets provides critical inter-subunit contacts to drive an active conformation structurally distinct from PKA [PMID:27066748], while NMR analysis establishes that cGMP acts through two-state conformational selection and cAMP is only a partial agonist that samples a third, partially autoinhibited state [PMID:26370085]. The N-terminal leucine zipper additionally carries C42, which forms an interchain disulfide upon oxidation that stabilizes the dimer [PMID:26132214] and, in stressed cardiomyocytes, drives PDE5 activation and PKG1α–PDE5 colocalization that underlies the antihypertrophic benefit of PDE5 inhibition [PMID:29545395]. Once active, PKG-1 phosphorylates a broad substrate network: it phosphorylates TSC2 (S1364/S1365) to activate its RHEB-GAP function, suppressing stress-stimulated mTORC1 and thereby limiting cardiac hypertrophy and promoting autophagy [PMID:30700906]; PKG1β forms a trimeric complex with IRAG and IP3 receptor type I at the ER, where phosphorylation of IRAG reduces IP3-mediated Ca2+ release to mediate smooth-muscle relaxation and platelet inhibition [PMID:21666108]; it phosphorylates VASP at Ser239 to drive a phosphorylation-dependent VASP–TRPC4 interaction that inhibits store-operated cation entry [PMID:17913834]; and it phosphorylates ENSA (S109) and ARPP19 (S104) at sites distinct from the MASTL-targeted residues in human platelets. A gain-of-function mutation, p.Arg177Gln, disrupts cGMP binding and renders PKG-1 constitutively active, causing familial thoracic aortic aneurysms and acute aortic dissections [PMID:23910461].","teleology":[{"year":1997,"claim":"Defining the gene architecture established that a single PRKG1 locus produces the two type I PKG isoforms, explaining how isoform-specific N-terminal functions arise from one gene.","evidence":"Gene cloning, 5'-RACE, Northern blot, and exon mapping","pmids":["9192852"],"confidence":"Medium","gaps":["Does not assign distinct functions or tissue distributions to Iα versus Iβ","Regulatory elements driving the alternative first exons not characterized"]},{"year":2007,"claim":"Identification of VASP-Ser239 phosphorylation and a phospho-dependent VASP–TRPC4 association revealed a molecular mechanism by which PKG-1α inhibits store-operated calcium entry.","evidence":"Ca2+ imaging, co-IP, immunocytochemistry, and PKG-1α inhibitor (DT-3) in glomerular mesangial cells","pmids":["17913834"],"confidence":"Medium","gaps":["Direct phosphorylation by PKG-1α not reconstituted in vitro","How pVASP physically inhibits TRPC4 gating unresolved"]},{"year":2007,"claim":"Linking the cGMP/PKG pathway to mitochondrial KATP channel opening and Zn2+/ERK signaling connected PKG activity to cardioprotection against oxidative stress.","evidence":"Fluorescence imaging of Zn2+ and mitochondrial membrane potential with pharmacological probes in adult rat cardiomyocytes","pmids":["17570352"],"confidence":"Medium","gaps":["Direct PKG substrate mediating Zn2+ release not identified","Relies on pharmacological inhibitors rather than genetic loss-of-function"]},{"year":2010,"claim":"Demonstrating that PKG inhibits TCF/β-catenin transcription via CTNNB1 repression and FOXO4-dependent sequestration extended PKG signaling into tumor-relevant transcriptional control.","evidence":"Luciferase reporters, co-IP, FOXO4 siRNA, and nuclear fractionation in colon cancer cells","pmids":["20348951"],"confidence":"Medium","gaps":["Direct PKG substrate in the JNK/FOXO4 axis not defined","Single cell-type context"]},{"year":2011,"claim":"Isoform-specific assembly of a PKG1β–IRAG–IP3R-I complex explained how cGMP suppresses ER calcium release for smooth-muscle relaxation and platelet inhibition.","evidence":"Co-IP, isoform-specific interaction mapping, and phosphorylation/functional assays in smooth muscle and platelets","pmids":["21666108"],"confidence":"Medium","gaps":["Summarized from prior reports rather than a single primary dataset","Structural basis of the trimeric complex unknown"]},{"year":2012,"claim":"Prkg1 knockout established an endogenous cGMP-PKG protective pathway in cochlear hair cells and neurons, broadening PKG function beyond the vasculature.","evidence":"Prkg1 knockout mice, auditory brainstem responses, PDE5-inhibitor rescue, and PAR immunostaining","pmids":["22270721"],"confidence":"High","gaps":["Direct PKG substrates mediating hair-cell survival not identified","Mechanistic link between PKG and PAR upregulation unresolved"]},{"year":2013,"claim":"A constitutively activating p.Arg177Gln mutation directly linked PRKG1 to a Mendelian aortic disease, showing that unregulated kinase activity disrupts smooth-muscle contraction.","evidence":"Exome/Sanger sequencing, kinase and myosin light-chain phosphorylation assays in patient fibroblasts, LOD analysis across families","pmids":["23910461"],"confidence":"High","gaps":["Full substrate consequences of constitutive activity in vascular cells not mapped","Tissue-specificity of the aortic phenotype not mechanistically explained"]},{"year":2014,"claim":"Multiple studies placed PKG within distinct upstream and downstream signaling contexts—heparin antiproliferative signaling, hypoxic miR-20a repression, and PVAT anticontractile function—defining its position in vascular regulation.","evidence":"PKG siRNA/inhibitors with ERK-Elk-1-MKP-1 readouts; miR-20a coding-region target mapping; PKG−/− mouse myography (years 2014, 2019)","pmids":["24911927","25447536","24095868"],"confidence":"Medium","gaps":["Direct PKG substrates in each context largely undefined","Cross-talk among these vascular roles not integrated"]},{"year":2015,"claim":"Biophysical and structural work resolved the activation mechanism: cGMP-driven two-state selection versus cAMP partial agonism, leucine-zipper C42 disulfide dimer stabilization, and a downstream CSE/H2S cardioprotective output.","evidence":"NMR of CNB-B; crystal structures of WT and C42L leucine zipper; adenoviral PKGIα/K390A with CSE inhibition in I/R models","pmids":["26370085","26132214","26036467"],"confidence":"High","gaps":["How CNB-B conformational states couple to full-length kinase activation in vivo not shown","Direct PKG substrate inducing CSE not identified"]},{"year":2016,"claim":"The cGMP-bound regulatory-domain crystal structure defined the active dimer interface and showed PKG's active conformation is distinct from PKA, providing a structural framework for cyclic-nucleotide selectivity.","evidence":"X-ray crystallography at 2.5 Å, SAXS, and site-directed mutagenesis","pmids":["27066748"],"confidence":"High","gaps":["Full-length holoenzyme structure not solved","Conformational transition to the catalytic domain not visualized"]},{"year":2018,"claim":"Redox-dead C42S knock-in mice demonstrated that C42 oxidation governs PKG1α-PDE5 colocalization and the therapeutic response to PDE5 inhibition, tying the structural disulfide to a subcellular signaling microdomain.","evidence":"PKG1αC42S knock-in mice, transaortic constriction, activity assays, immunofluorescence colocalization, pharmacological dissection","pmids":["29545395"],"confidence":"High","gaps":["Mechanism by which oxidized PKG1α activates PDE5 not defined","Generality beyond cardiac stress unknown"]},{"year":2019,"claim":"Identification of TSC2-S1364/S1365 as a direct PKG substrate, validated by phospho-mutant knock-in mice, established PKG's antihypertrophic and pro-autophagic action through mTORC1 suppression.","evidence":"In vitro kinase assay, phospho-specific antibodies, TSC2-S1365A/S1365E knock-in mice, transaortic constriction, echocardiography","pmids":["30700906"],"confidence":"High","gaps":["Stress-specific selectivity over basal mTORC1 not fully explained","Whether the same axis operates in non-cardiac tissues not established here"]},{"year":2019,"claim":"An sGC→cGMP→PKG→p38→PGC-1α epistasis defined a PKG-driven mitochondrial biogenesis program in renal proximal tubule cells.","evidence":"Pharmacological PKG and p38 inhibitors in vitro and in vivo, nuclear phospho-PGC-1α fractionation, biogenesis markers","pmids":["31841384"],"confidence":"Medium","gaps":["Direct PKG substrate upstream of p38 not identified","Reliance on pharmacological epistasis without genetic PKG deletion"]},{"year":2020,"claim":"Reconstitution showing PKG phosphorylates ENSA-S109 and ARPP19-S104 at sites distinct from MASTL targets revealed PKG input into the PP2A-regulatory module in anucleate platelets.","evidence":"Platelet proteomics, recombinant PKG kinase assays with ENSA/ARPP19 phospho-mutants, cGMP-elevating agents","pmids":["32085646"],"confidence":"Medium","gaps":["Functional consequence of these phosphorylations for PP2A activity in platelets not resolved","Single-lab finding"]},{"year":2024,"claim":"Placing PRKG1 upstream of PINK1 and the STING/IRF3 axis connected PKG to mitochondrial quality control and inflammatory suppression in cardiotoxicity.","evidence":"AAV-mediated cardiac PRKG1 overexpression/silencing, RNA-seq, PINK1/STING/IRF3 Western blots, mitochondrial assays in mouse models","pmids":["39059761"],"confidence":"Medium","gaps":["Direct PKG substrate activating PINK1 not identified","Whether the effect is kinase-dependent not isolated"]},{"year":null,"claim":"How isoform-specific targeting, redox state, and the diverse substrate set are integrated into tissue-specific PKG outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No full-length holoenzyme structure capturing activation","Unified substrate-selectivity logic across cardiac, vascular, renal, and platelet contexts not established","Mechanism coupling C42 oxidation to specific substrate phosphorylation undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,7,8]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,8]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[3,4]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[9,13,17]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[7]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6,8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,7,16,17]},{"term_id":"R-HSA-397014","term_label":"Muscle contraction","supporting_discovery_ids":[0,13,15]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[1]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[7]}],"complexes":["PKG1β–IRAG–IP3R-I ER complex"],"partners":["IRAG1","ITPR1","VASP","TRPC4","PDE5A","TSC2","ENSA","ARPP19"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13976","full_name":"cGMP-dependent protein kinase 1","aliases":["cGMP-dependent protein kinase I","cGKI"],"length_aa":671,"mass_kda":76.4,"function":"Serine/threonine protein kinase that acts as a key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smooth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates IRAG1 and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling also alters gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q13976/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PRKG1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PRKG1","total_profiled":1310},"omim":[{"mim_id":"615436","title":"AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8","url":"https://www.omim.org/entry/615436"},{"mim_id":"615343","title":"PULMONARY HYPERTENSION, PRIMARY, 3; PPH3","url":"https://www.omim.org/entry/615343"},{"mim_id":"612935","title":"MYOSIN PHOSPHATASE RHO-INTERACTING PROTEIN; MPRIP","url":"https://www.omim.org/entry/612935"},{"mim_id":"611184","title":"PIEZO-TYPE MECHANOSENSITIVE ION CHANNEL COMPONENT 1; PIEZO1","url":"https://www.omim.org/entry/611184"},{"mim_id":"607086","title":"AORTIC ANEURYSM, FAMILIAL THORACIC 1; AAT1","url":"https://www.omim.org/entry/607086"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":64.3}],"url":"https://www.proteinatlas.org/search/PRKG1"},"hgnc":{"alias_symbol":["PGK","PKG","PKG1"],"prev_symbol":["PRKGR1B","PRKG1B"]},"alphafold":{"accession":"Q13976","domains":[{"cath_id":"2.60.120.10","chopping":"73-196","consensus_level":"high","plddt":86.7943,"start":73,"end":196},{"cath_id":"2.60.120.10","chopping":"219-318","consensus_level":"high","plddt":85.5114,"start":219,"end":318},{"cath_id":"3.30.200.20","chopping":"344-438","consensus_level":"high","plddt":92.6337,"start":344,"end":438},{"cath_id":"1.10.510.10","chopping":"444-628","consensus_level":"high","plddt":93.2311,"start":444,"end":628}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13976","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13976-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13976-F1-predicted_aligned_error_v6.png","plddt_mean":86.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PRKG1","jax_strain_url":"https://www.jax.org/strain/search?query=PRKG1"},"sequence":{"accession":"Q13976","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13976.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13976/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13976"}},"corpus_meta":[{"pmid":"3453121","id":"PMC_3453121","title":"Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene.","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3453121","citation_count":405,"is_preprint":false},{"pmid":"3440520","id":"PMC_3440520","title":"Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter.","date":"1987","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/3440520","citation_count":350,"is_preprint":false},{"pmid":"1690874","id":"PMC_1690874","title":"Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis.","date":"1990","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1690874","citation_count":226,"is_preprint":false},{"pmid":"23910461","id":"PMC_23910461","title":"Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.","date":"2013","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23910461","citation_count":195,"is_preprint":false},{"pmid":"2823118","id":"PMC_2823118","title":"The testis-specific phosphoglycerate kinase gene pgk-2 is a recruited retroposon.","date":"1987","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2823118","citation_count":171,"is_preprint":false},{"pmid":"28465425","id":"PMC_28465425","title":"Plasma Membrane Association by N-Acylation Governs PKG Function in Toxoplasma gondii.","date":"2017","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/28465425","citation_count":153,"is_preprint":false},{"pmid":"11751274","id":"PMC_11751274","title":"In vitro production and nuclear transfer affect dosage compensation of the X-linked gene transcripts G6PD, PGK, and Xist in preimplantation bovine embryos.","date":"2002","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/11751274","citation_count":141,"is_preprint":false},{"pmid":"1426623","id":"PMC_1426623","title":"Differential transcription of Pgk genes during spermatogenesis in the mouse.","date":"1992","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/1426623","citation_count":136,"is_preprint":false},{"pmid":"3540610","id":"PMC_3540610","title":"Efficient expression of the Saccharomyces cerevisiae PGK gene depends on an upstream activation sequence but does not require TATA sequences.","date":"1986","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3540610","citation_count":129,"is_preprint":false},{"pmid":"17248765","id":"PMC_17248765","title":"Electrophoretic variation for x-chromosome-linked phosphoglycerate kinase (pgk-1) in the mouse.","date":"1977","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17248765","citation_count":121,"is_preprint":false},{"pmid":"1958476","id":"PMC_1958476","title":"X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post-chemotherapy females.","date":"1991","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/1958476","citation_count":118,"is_preprint":false},{"pmid":"30700906","id":"PMC_30700906","title":"PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/30700906","citation_count":114,"is_preprint":false},{"pmid":"2685568","id":"PMC_2685568","title":"Transcriptional control of the Saccharomyces cerevisiae PGK gene by RAP1.","date":"1989","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2685568","citation_count":112,"is_preprint":false},{"pmid":"9192852","id":"PMC_9192852","title":"Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1).","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9192852","citation_count":103,"is_preprint":false},{"pmid":"25297462","id":"PMC_25297462","title":"The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism.","date":"2015","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25297462","citation_count":102,"is_preprint":false},{"pmid":"33186350","id":"PMC_33186350","title":"Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway.","date":"2020","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/33186350","citation_count":98,"is_preprint":false},{"pmid":"31337673","id":"PMC_31337673","title":"Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice.","date":"2019","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/31337673","citation_count":91,"is_preprint":false},{"pmid":"29030485","id":"PMC_29030485","title":"Crosstalk between PKA and PKG controls pH-dependent host cell egress of Toxoplasma gondii.","date":"2017","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/29030485","citation_count":83,"is_preprint":false},{"pmid":"11536432","id":"PMC_11536432","title":"Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice.","date":"2001","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/11536432","citation_count":82,"is_preprint":false},{"pmid":"37531438","id":"PMC_37531438","title":"NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37531438","citation_count":75,"is_preprint":false},{"pmid":"15169860","id":"PMC_15169860","title":"Activity of cGMP-dependent protein kinase (PKG) affects sucrose responsiveness and habituation in Drosophila melanogaster.","date":"2004","source":"Learning & memory (Cold Spring Harbor, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15169860","citation_count":73,"is_preprint":false},{"pmid":"16325279","id":"PMC_16325279","title":"Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.","date":"2005","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/16325279","citation_count":73,"is_preprint":false},{"pmid":"2027764","id":"PMC_2027764","title":"Determining transcript number using the polymerase chain reaction: Pgk-2, mP2, and PGK-2 transgene mRNA levels during spermatogenesis.","date":"1991","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2027764","citation_count":73,"is_preprint":false},{"pmid":"22270721","id":"PMC_22270721","title":"cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function.","date":"2012","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22270721","citation_count":72,"is_preprint":false},{"pmid":"32359426","id":"PMC_32359426","title":"Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity.","date":"2020","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/32359426","citation_count":72,"is_preprint":false},{"pmid":"25273530","id":"PMC_25273530","title":"Human exosomal placenta-associated miR-517a-3p modulates the expression of PRKG1 mRNA in Jurkat cells.","date":"2014","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/25273530","citation_count":70,"is_preprint":false},{"pmid":"27581840","id":"PMC_27581840","title":"Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27581840","citation_count":66,"is_preprint":false},{"pmid":"20348951","id":"PMC_20348951","title":"PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20348951","citation_count":63,"is_preprint":false},{"pmid":"35479330","id":"PMC_35479330","title":"Cyclic GMP and PKG Signaling in Heart Failure.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35479330","citation_count":62,"is_preprint":false},{"pmid":"29766323","id":"PMC_29766323","title":"cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway.","date":"2018","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/29766323","citation_count":62,"is_preprint":false},{"pmid":"17222195","id":"PMC_17222195","title":"PGK deficiency.","date":"2007","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/17222195","citation_count":61,"is_preprint":false},{"pmid":"17570352","id":"PMC_17570352","title":"NO mobilizes intracellular Zn2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes.","date":"2007","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/17570352","citation_count":61,"is_preprint":false},{"pmid":"2347494","id":"PMC_2347494","title":"Limited bidirectional activity of two housekeeping gene promoters: human HPRT and PGK.","date":"1990","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/2347494","citation_count":59,"is_preprint":false},{"pmid":"1549104","id":"PMC_1549104","title":"Protein-DNA interactions associated with the onset of testis-specific expression of the mammalian Pgk-2 gene.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1549104","citation_count":58,"is_preprint":false},{"pmid":"3533726","id":"PMC_3533726","title":"Transcription and processing signals in the 3-phosphoglycerate kinase (PGK) gene from Aspergillus nidulans.","date":"1986","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/3533726","citation_count":58,"is_preprint":false},{"pmid":"32860248","id":"PMC_32860248","title":"The NO-cGMP-PKG pathway in skeletal remodeling.","date":"2020","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32860248","citation_count":51,"is_preprint":false},{"pmid":"22850435","id":"PMC_22850435","title":"Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.","date":"2012","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22850435","citation_count":49,"is_preprint":false},{"pmid":"21666108","id":"PMC_21666108","title":"IRAG and novel PKG targeting in the cardiovascular system.","date":"2011","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21666108","citation_count":48,"is_preprint":false},{"pmid":"36429131","id":"PMC_36429131","title":"The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36429131","citation_count":48,"is_preprint":false},{"pmid":"26370085","id":"PMC_26370085","title":"Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26370085","citation_count":47,"is_preprint":false},{"pmid":"24095868","id":"PMC_24095868","title":"cGMP-dependent protein kinase (PKG) mediates the anticontractile capacity of perivascular adipose tissue.","date":"2013","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/24095868","citation_count":43,"is_preprint":false},{"pmid":"2156237","id":"PMC_2156237","title":"Molecular evolution of the human Pgk-2 retroposon.","date":"1990","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2156237","citation_count":43,"is_preprint":false},{"pmid":"39308187","id":"PMC_39308187","title":"Bifidobacterium pseudolongum-Derived Bile Acid from Dietary Carvacrol and Thymol Supplementation Attenuates Colitis via cGMP-PKG-mTORC1 Pathway.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39308187","citation_count":42,"is_preprint":false},{"pmid":"35950928","id":"PMC_35950928","title":"The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders.","date":"2022","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/35950928","citation_count":42,"is_preprint":false},{"pmid":"28265120","id":"PMC_28265120","title":"A genome-wide gene-by-trauma interaction study of alcohol misuse in two independent cohorts identifies PRKG1 as a risk locus.","date":"2017","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/28265120","citation_count":41,"is_preprint":false},{"pmid":"36818566","id":"PMC_36818566","title":"The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies.","date":"2023","source":"Aging and disease","url":"https://pubmed.ncbi.nlm.nih.gov/36818566","citation_count":40,"is_preprint":false},{"pmid":"3916724","id":"PMC_3916724","title":"Molecular cloning of the 3-phosphoglycerate kinase (PGK) gene from Aspergillus nidulans.","date":"1985","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/3916724","citation_count":39,"is_preprint":false},{"pmid":"2685757","id":"PMC_2685757","title":"Characterization of the transcriptional potency of sub-elements of the UAS of the yeast PGK gene in a PGK mini-promoter.","date":"1989","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2685757","citation_count":38,"is_preprint":false},{"pmid":"8441629","id":"PMC_8441629","title":"A factor stimulating transcription of the testis-specific Pgk-2 gene recognizes a sequence similar to the binding site for a transcription inhibitor of the somatic-type Pgk-1 gene.","date":"1993","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8441629","citation_count":36,"is_preprint":false},{"pmid":"34419525","id":"PMC_34419525","title":"Gastrodin promotes hippocampal neurogenesis via PDE9-cGMP-PKG pathway in mice following cerebral ischemia.","date":"2021","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/34419525","citation_count":36,"is_preprint":false},{"pmid":"30782798","id":"PMC_30782798","title":"Self-regulation and the foraging gene (PRKG1) in humans.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30782798","citation_count":34,"is_preprint":false},{"pmid":"27066748","id":"PMC_27066748","title":"Crystal Structure of PKG I:cGMP Complex Reveals a cGMP-Mediated Dimeric Interface that Facilitates cGMP-Induced Activation.","date":"2016","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/27066748","citation_count":34,"is_preprint":false},{"pmid":"17876305","id":"PMC_17876305","title":"Cardioprotection: spotlight on PKG.","date":"2007","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17876305","citation_count":33,"is_preprint":false},{"pmid":"36706596","id":"PMC_36706596","title":"Semaglutide inhibits ischemia/reperfusion-induced cardiomyocyte apoptosis through activating PKG/PKCε/ERK1/2 pathway.","date":"2023","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36706596","citation_count":32,"is_preprint":false},{"pmid":"9851989","id":"PMC_9851989","title":"The EIIGlc protein is involved in glucose-mediated activation of Escherichia coli gapA and gapB-pgk transcription.","date":"1998","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/9851989","citation_count":32,"is_preprint":false},{"pmid":"29545395","id":"PMC_29545395","title":"Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.","date":"2018","source":"Circulation. Heart failure","url":"https://pubmed.ncbi.nlm.nih.gov/29545395","citation_count":31,"is_preprint":false},{"pmid":"12765880","id":"PMC_12765880","title":"Pulmonary PKG-1 is upregulated following chronic hypoxia.","date":"2003","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12765880","citation_count":30,"is_preprint":false},{"pmid":"35289711","id":"PMC_35289711","title":"Phosphatidic acid suppresses autophagy through competitive inhibition by binding GAPC (glyceraldehyde-3-phosphate dehydrogenase) and PGK (phosphoglycerate kinase) proteins.","date":"2022","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/35289711","citation_count":29,"is_preprint":false},{"pmid":"30841438","id":"PMC_30841438","title":"Propranolol selectively inhibits cervical cancer cell growth by suppressing the cGMP/PKG pathway.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30841438","citation_count":28,"is_preprint":false},{"pmid":"27442293","id":"PMC_27442293","title":"PRKG1 and genetic diagnosis of early-onset thoracic aortic disease.","date":"2016","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/27442293","citation_count":27,"is_preprint":false},{"pmid":"17913834","id":"PMC_17913834","title":"Association of VASP with TRPC4 in PKG-mediated inhibition of the store-operated calcium response in mesangial cells.","date":"2007","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17913834","citation_count":27,"is_preprint":false},{"pmid":"33542225","id":"PMC_33542225","title":"The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33542225","citation_count":27,"is_preprint":false},{"pmid":"23139241","id":"PMC_23139241","title":"Transcriptional and post-transcriptional regulation of cGMP-dependent protein kinase (PKG-I): pathophysiological significance.","date":"2012","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/23139241","citation_count":25,"is_preprint":false},{"pmid":"28705807","id":"PMC_28705807","title":"Augmentation of cGMP/PKG pathway and colonic motility by hydrogen sulfide.","date":"2017","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28705807","citation_count":25,"is_preprint":false},{"pmid":"1879353","id":"PMC_1879353","title":"Timing of paternal Pgk-1 expression in embryos of transgenic mice.","date":"1991","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1879353","citation_count":25,"is_preprint":false},{"pmid":"33814252","id":"PMC_33814252","title":"Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG.","date":"2021","source":"Journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/33814252","citation_count":24,"is_preprint":false},{"pmid":"29300939","id":"PMC_29300939","title":"cGMP/PKG-I Pathway-Mediated GLUT1/4 Regulation by NO in Female Rat Granulosa Cells.","date":"2018","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29300939","citation_count":23,"is_preprint":false},{"pmid":"24911927","id":"PMC_24911927","title":"Heparin responses in vascular smooth muscle cells involve cGMP-dependent protein kinase (PKG).","date":"2014","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24911927","citation_count":23,"is_preprint":false},{"pmid":"32085646","id":"PMC_32085646","title":"The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32085646","citation_count":23,"is_preprint":false},{"pmid":"31841384","id":"PMC_31841384","title":"Elucidation of cGMP-dependent induction of mitochondrial biogenesis through PKG and p38 MAPK in the kidney.","date":"2019","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31841384","citation_count":23,"is_preprint":false},{"pmid":"27553203","id":"PMC_27553203","title":"Helional induces Ca2+ decrease and serotonin secretion of QGP-1 cells via a PKG-mediated pathway.","date":"2016","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27553203","citation_count":23,"is_preprint":false},{"pmid":"38637328","id":"PMC_38637328","title":"Isthmin-1 alleviates cardiac ischaemia/reperfusion injury through cGMP-PKG signalling pathway.","date":"2024","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/38637328","citation_count":21,"is_preprint":false},{"pmid":"25447536","id":"PMC_25447536","title":"MiR-20a regulates the PRKG1 gene by targeting its coding region in pulmonary arterial smooth muscle cells.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/25447536","citation_count":21,"is_preprint":false},{"pmid":"36016499","id":"PMC_36016499","title":"Chronological attenuation of NPRA/PKG/AMPK signaling promotes vascular aging and elevates blood pressure.","date":"2022","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/36016499","citation_count":21,"is_preprint":false},{"pmid":"35241647","id":"PMC_35241647","title":"Kinase activity profiling identifies putative downstream targets of cGMP/PKG signaling in inherited retinal neurodegeneration.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35241647","citation_count":21,"is_preprint":false},{"pmid":"26036467","id":"PMC_26036467","title":"Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα.","date":"2015","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26036467","citation_count":21,"is_preprint":false},{"pmid":"28679626","id":"PMC_28679626","title":"The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK.","date":"2017","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28679626","citation_count":20,"is_preprint":false},{"pmid":"7923142","id":"PMC_7923142","title":"Clonal determination by the fragile X (FMR1) and phosphoglycerate kinase (PGK) genes in hematological malignancies.","date":"1994","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7923142","citation_count":20,"is_preprint":false},{"pmid":"23136350","id":"PMC_23136350","title":"A cGMP-dependent protein kinase (PKG) controls synaptic transmission tolerance to acute oxidative stress at the Drosophila larval neuromuscular junction.","date":"2012","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/23136350","citation_count":20,"is_preprint":false},{"pmid":"30871887","id":"PMC_30871887","title":"The natural history of type B aortic dissection in patients with PRKG1 mutation c.530G>A (p.Arg177Gln).","date":"2019","source":"Journal of vascular surgery","url":"https://pubmed.ncbi.nlm.nih.gov/30871887","citation_count":19,"is_preprint":false},{"pmid":"30981710","id":"PMC_30981710","title":"Vasodilatory effect of kaempferol-7-O-α-L-rhamnopyranoside via NO-cGMP-PKG signaling.","date":"2019","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/30981710","citation_count":19,"is_preprint":false},{"pmid":"32717242","id":"PMC_32717242","title":"Empagliflozin dilates the rabbit aorta by activating PKG and voltage-dependent K+ channels.","date":"2020","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32717242","citation_count":19,"is_preprint":false},{"pmid":"35489325","id":"PMC_35489325","title":"Corallodiscus flabellata B. L. Burtt extract and isonuomioside A ameliorate Aβ25-35-induced brain injury by inhibiting apoptosis, oxidative stress, and autophagy via the NMDAR2B/CamK Ⅱ/PKG pathway.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35489325","citation_count":19,"is_preprint":false},{"pmid":"26132214","id":"PMC_26132214","title":"Structures of cGMP-Dependent Protein Kinase (PKG) Iα Leucine Zippers Reveal an Interchain Disulfide Bond Important for Dimer Stability.","date":"2015","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26132214","citation_count":19,"is_preprint":false},{"pmid":"2545537","id":"PMC_2545537","title":"Cloning and characterization of the Escherichia coli phosphoglycerate kinase (pgk) gene.","date":"1989","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/2545537","citation_count":19,"is_preprint":false},{"pmid":"7603527","id":"PMC_7603527","title":"Molecular genetic heterogeneity of phosphoglycerate kinase (PGK) deficiency.","date":"1995","source":"Muscle & nerve. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/7603527","citation_count":18,"is_preprint":false},{"pmid":"26318600","id":"PMC_26318600","title":"Hydrogen sulfide and PKG in ischemia-reperfusion injury: sources, signaling, accelerators and brakes.","date":"2015","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26318600","citation_count":17,"is_preprint":false},{"pmid":"26375024","id":"PMC_26375024","title":"PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26375024","citation_count":17,"is_preprint":false},{"pmid":"2687242","id":"PMC_2687242","title":"Differential expression of gap and pgk genes within the gap operon of Zymomonas mobilis.","date":"1989","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/2687242","citation_count":17,"is_preprint":false},{"pmid":"33013408","id":"PMC_33013408","title":"Protoporphyrin IX Stimulates Melanogenesis, Melanocyte Dendricity, and Melanosome Transport Through the cGMP/PKG Pathway.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33013408","citation_count":17,"is_preprint":false},{"pmid":"34744735","id":"PMC_34744735","title":"Emodin Interferes With Nitroglycerin-Induced Migraine in Rats Through CGMP-PKG Pathway.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34744735","citation_count":17,"is_preprint":false},{"pmid":"39059761","id":"PMC_39059761","title":"Vericiguat attenuates doxorubicin-induced cardiotoxicity through the PRKG1/PINK1/STING axis.","date":"2024","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39059761","citation_count":16,"is_preprint":false},{"pmid":"31269900","id":"PMC_31269900","title":"A post-GWAS confirming effects of PRKG1 gene on milk fatty acids in a Chinese Holstein dairy population.","date":"2019","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31269900","citation_count":16,"is_preprint":false},{"pmid":"7808400","id":"PMC_7808400","title":"The yeast protein Gcr1p binds to the PGK UAS and contributes to the activation of transcription of the PGK gene.","date":"1994","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/7808400","citation_count":16,"is_preprint":false},{"pmid":"31778749","id":"PMC_31778749","title":"Genes of the cGMP-PKG-Ca2+ signaling pathway are alternatively spliced in cardiomyopathy: Role of RBFOX2.","date":"2019","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/31778749","citation_count":15,"is_preprint":false},{"pmid":"38734687","id":"PMC_38734687","title":"Chronic circadian rhythm disorder induces heart failure with preserved ejection fraction-like phenotype through the Clock-sGC-cGMP-PKG1 signaling pathway.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38734687","citation_count":14,"is_preprint":false},{"pmid":"35404079","id":"PMC_35404079","title":"A G-Protein-Coupled Receptor Modulates Gametogenesis via PKG-Mediated Signaling Cascade in Plasmodium berghei.","date":"2022","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/35404079","citation_count":14,"is_preprint":false},{"pmid":"35850398","id":"PMC_35850398","title":"Prenatal chronic stress impairs the learning and memory ability via inhibition of the NO/cGMP/PKG pathway in the Hippocampus of offspring.","date":"2022","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/35850398","citation_count":14,"is_preprint":false},{"pmid":"17707440","id":"PMC_17707440","title":"Sodium nitroprusside activates p38 mitogen activated protein kinase through a cGMP/PKG independent mechanism.","date":"2007","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17707440","citation_count":14,"is_preprint":false},{"pmid":"28827895","id":"PMC_28827895","title":"The Drosophila foraging gene human orthologue PRKG1 predicts individual differences in the effects of early adversity on maternal sensitivity.","date":"2016","source":"Cognitive development","url":"https://pubmed.ncbi.nlm.nih.gov/28827895","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50751,"output_tokens":5971,"usd":0.120909,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14795,"output_tokens":5084,"usd":0.100538,"stage2_stop_reason":"end_turn"},"total_usd":0.221447,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"A gain-of-function missense mutation in PRKG1 (p.Arg177Gln) disrupts binding to the high-affinity cGMP binding site within the regulatory domain, rendering PKG-1 constitutively active even in the absence of cGMP. This constitutive activity leads to decreased phosphorylation of the myosin regulatory light chain in fibroblasts, predicted to cause decreased contraction of vascular smooth-muscle cells, and causes familial thoracic aortic aneurysms and acute aortic dissections.\",\n      \"method\": \"Exome sequencing, Sanger sequencing, functional assay of PKG-1 activity and myosin light chain phosphorylation in patient fibroblasts, LOD score analysis\",\n      \"journal\": \"American Journal of Human Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic and biochemical validation; constitutive kinase activity demonstrated in patient cells with defined substrate (myosin RLC phosphorylation); replicated in multiple independent families\",\n      \"pmids\": [\"23910461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PKG1 (PRKG1) phosphorylates TSC2 at S1365 (mouse) / S1364-S1365 (human) in cardiomyocytes and fibroblasts. This phosphorylation activates TSC2's GTPase-activating function toward RHEB, thereby inhibiting stress-stimulated mTORC1 activity without altering basal mTORC1. PKG1-mediated TSC2 phosphorylation is required for PKG1's suppression of hypertrophy and stimulation of autophagy in cardiomyocytes under pressure overload.\",\n      \"method\": \"In vitro kinase assay, phospho-specific antibodies, homozygous knock-in mice (TSC2-S1365A phosphosilencing and S1365E phosphomimicking), transaortic constriction model, echocardiography, cell culture gain/loss-of-function\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay identifying direct substrate, validated with knock-in mutagenesis in vivo and multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"30700906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PRKG1 is a single-copy gene with 19 exons spanning at least 220 kb that encodes both the type Iα and type Iβ isoforms of cGMP-dependent protein kinase via alternative first exons. The two isoforms differ only in their N-terminal regions, each driven by distinct transcription initiation sites. Several splice sites are conserved with the Drosophila DG2 gene and correlate with boundaries between functional domains of type I cGK.\",\n      \"method\": \"Gene cloning, 5′-RACE, Northern blot analysis, exon mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cloning and structural characterization with 5′-RACE and Northern blot; single lab but multiple orthogonal molecular methods\",\n      \"pmids\": [\"9192852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of the PKG Iα regulatory domain bound to cGMP at 2.5 Å reveals that two regulatory domains form a symmetric dimer in which cGMP molecules bound at the high-affinity (B) pockets provide critical inter-subunit contacts. Small-angle X-ray scattering and mutagenesis support the dimer model and indicate the dimer interface modulates kinase activation. The active conformation of PKG is structurally distinct from that of protein kinase A.\",\n      \"method\": \"X-ray crystallography (2.5 Å), small-angle X-ray scattering (SAXS), site-directed mutagenesis\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution crystal structure combined with SAXS and mutagenesis in a single rigorous study\",\n      \"pmids\": [\"27066748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"cAMP is a partial agonist for PKG Iα. NMR analysis of the cyclic nucleotide-binding domain B shows that cGMP activation follows a two-state conformational selection model, whereas cAMP partial agonism arises from sampling of a third, partially autoinhibited conformational state not accessed by cGMP.\",\n      \"method\": \"NMR spectroscopy of apo, cGMP-bound, and cAMP-bound forms of PKG cyclic nucleotide-binding domain B; comparative conformational analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR with functional mechanistic interpretation; single lab but rigorous biophysical multi-state analysis\",\n      \"pmids\": [\"26370085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The N-terminal leucine zipper (LZ) domain of PKG Iα contains C42, which forms an interchain disulfide bond upon oxidation. Crystal structures of wild-type and C42L mutant LZ domains show that the C42–C42′ disulfide bond dramatically stabilizes the PKG Iα dimer, and the C42L mutant mimics the structural conformation of the oxidized wild-type LZ.\",\n      \"method\": \"X-ray crystallography of wild-type and C42L leucine zipper domains, structural comparison\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures of both WT and mutant with direct structural evidence for disulfide-mediated dimer stabilization\",\n      \"pmids\": [\"26132214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PKG1α oxidation at C42 (forming a homodimer disulfide) contributes to PDE5 activation and co-localization of PDE5 with PKG1α in stressed cardiomyocytes. Knock-in mice expressing redox-dead PKG1α (C42S) show minimal PDE5 activation after pressure overload and little colocalization of PDE5 with PKG1αC42S, resulting in loss of the antihypertrophic/antifibrotic benefit of PDE5 inhibition (sildenafil) but not sGC stimulation (BAY602770).\",\n      \"method\": \"Knock-in mouse model (PKG1αC42S), transaortic constriction, PKG activity assay, immunofluorescence co-localization, cardiac phenotyping\",\n      \"journal\": \"Circulation: Heart Failure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knock-in genetic model with in vivo pressure overload, multiple orthogonal methods (activity assay, co-localization, pharmacological dissection), defining a redox-dependent PKG1α-PDE5 subcellular interaction\",\n      \"pmids\": [\"29545395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PKG1β (but not PKG1α) forms a trimeric complex with IRAG (inositol trisphosphate receptor-associated cGMP-kinase substrate) and IP3 receptor type I at the endoplasmic reticulum. Phosphorylation of IRAG by PKG1β upon cGMP stimulation reduces IP3-mediated intracellular calcium release, thereby mediating smooth muscle relaxation and inhibition of platelet activation.\",\n      \"method\": \"Co-immunoprecipitation, isoform-specific interaction mapping, phosphorylation assays, functional studies in smooth muscle and platelets\",\n      \"journal\": \"American Journal of Physiology: Heart and Circulatory Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP establishing trimeric complex, phosphorylation demonstrated, functional readout in two cell types; review paper summarizing direct experimental data from multiple publications\",\n      \"pmids\": [\"21666108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PKG-1α mediates inhibition of the store-operated cation channel (SOC/TRPC4) in human glomerular mesangial cells via phosphorylation of VASP at Ser239. PKG-1α-phosphorylated VASP (pSer239-VASP) associates with TRPC4 by co-immunoprecipitation and co-immunostaining, while unphosphorylated VASP does not, demonstrating a phosphorylation-dependent interaction that underlies SOC inhibition.\",\n      \"method\": \"Fura-2 Ca2+ imaging, RT-PCR, Western blotting, immunocytochemistry, co-immunoprecipitation, specific PKG-1α inhibitor (DT-3), 8-Br-cGMP\",\n      \"journal\": \"American Journal of Physiology: Renal Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP identifying phosphorylation-dependent VASP–TRPC4 interaction, pharmacological and molecular validation in same study\",\n      \"pmids\": [\"17913834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Genetic deletion of Prkg1 in mice leads to greater vulnerability to and reduced recovery from noise-induced hearing loss (NIHL). Prkg1 is expressed in cochlear hair cells and neurons and partially overlaps with PDE5 expression. Pharmacological elevation of cGMP by vardenafil (PDE5 inhibitor) almost completely prevented NIHL in a Prkg1-dependent manner, and induced poly(ADP-ribose) (PAR) upregulation in hair cells and spiral ganglion via Prkg1, indicating an endogenous cGMP-Prkg1 protective signaling pathway in the inner ear.\",\n      \"method\": \"Prkg1 knockout mice, auditory brainstem response measurements, immunohistochemistry for Prkg1 and Pde5, vardenafil treatment, PAR immunostaining\",\n      \"journal\": \"Nature Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with defined cellular phenotype, pharmacological rescue with Prkg1-dependent readout, multiple orthogonal methods in one study\",\n      \"pmids\": [\"22270721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PKG activation in colon cancer cells inhibits TCF-dependent transcription through two mechanisms: (1) transcriptional repression of the CTNNB1 (β-catenin) gene, reducing β-catenin mRNA and protein; and (2) JNK-dependent sequestration of β-catenin by FOXO4, which requires nuclear translocation of FOXO4. FOXO4-specific siRNA completely blocked PKG's inhibitory effect on TCF activity.\",\n      \"method\": \"Luciferase reporter assays (CTNNB1 and TCF promoters), Western blotting, co-immunoprecipitation (β-catenin/FOXO4), siRNA knockdown, nuclear fractionation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and siRNA with reporter assays, multiple orthogonal methods in single lab study\",\n      \"pmids\": [\"20348951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In isolated adult rat cardiomyocytes, NO mobilizes intracellular free Zn2+ via the cGMP/PKG pathway through opening of mitochondrial K(ATP) channels. PKG inhibitor KT5823 blocked Zn2+ release by SNAP, while the PKG activator 8-Br-cGMP mimicked NO action. The released Zn2+ activates ERK, which mediates protection against H2O2-induced loss of mitochondrial membrane potential.\",\n      \"method\": \"Fluorescence imaging (Newport Green DCF for Zn2+, TMRE for mitochondrial membrane potential), pharmacological inhibitors/activators (KT5823, 8-Br-cGMP, ODQ, NS2028, 5-HD, diazoxide, PD98059), Western blot for ERK phosphorylation\",\n      \"journal\": \"Cardiovascular Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live-cell imaging with multiple pharmacological probes in primary cardiomyocytes, single lab\",\n      \"pmids\": [\"17570352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PKG-Iα overexpression in cardiomyocytes and mice induces expression of the H2S-producing enzyme cystathionine-γ-lyase (CSE), increasing H2S levels, without affecting CBS or MPST. Inhibition of CSE by PAG abolishes the cardioprotective effect of PKG-Iα against ischemia/reperfusion injury in vitro and in vivo, indicating H2S is a downstream mediator of PKG-Iα cardioprotection. An inactive kinase-dead mutant (K390A) does not induce CSE, confirming kinase-dependent mechanism.\",\n      \"method\": \"Adenoviral overexpression of PKGIα and inactive K390A mutant, in vitro ischemia/reperfusion (necrosis/apoptosis assays), in vivo mouse I/R (infarct size, echocardiography), Western blotting for CSE/CBS/MPST, H2S measurement, CSE inhibitor (PAG)\",\n      \"journal\": \"Basic Research in Cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase-dead mutant controls and CSE inhibitor rescue establish mechanism; single lab but multiple orthogonal in vitro/in vivo methods\",\n      \"pmids\": [\"26036467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PKG (PRKG1) is required for the anticontractile function of perivascular adipose tissue (PVAT) in mouse resistance arteries. PKG−/− arteries lack PVAT anticontractile function, and DT-2/ODQ inhibition of PKG in PKG+/+ arteries recapitulates this loss. PKG activation by ANP rescues hypoxia-induced loss of PVAT function only in PKG+/+ mice. PKG is also necessary for normal paracrine signaling from adipocytes to smooth muscle and endothelium, and its absence reduces adipocyte adiponectin expression.\",\n      \"method\": \"Wire myography, PKG−/− mice, adiponectin−/− mice, pharmacological inhibitors (DT-2, ODQ), ANP stimulation, solution transfer experiments\",\n      \"journal\": \"Cardiovascular Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with defined functional readout, multiple pharmacological and genetic controls in one study\",\n      \"pmids\": [\"24095868\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-20a, upregulated by hypoxia in pulmonary artery smooth muscle cells, directly represses PRKG1 expression by targeting two binding sites within the coding region (not the 3′ UTR) of PRKG1 mRNA. Functional studies showed miR-20a promotes PASMC proliferation and migration while inhibiting differentiation, phenocopying loss of PRKG1.\",\n      \"method\": \"miRNA target site mapping in PRKG1 coding region, miR-20a overexpression/inhibition, cell proliferation/migration assays, hypoxia cell model\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct mapping of miR-20a binding within PRKG1 coding region with functional rescue; single lab with multiple functional readouts\",\n      \"pmids\": [\"25447536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PKG-1 expression and activity are approximately two-fold upregulated in the pulmonary vasculature of chronically hypoxic rats, localized specifically to the vasculature by quantitative immunohistochemistry. Despite this upregulation, vasodilatory responses to 8-BrcGMP are attenuated after chronic hypoxia, indicating that the impaired vasodilation is not due to decreased PKG-1 expression/activity.\",\n      \"method\": \"Isolated perfused lung vasodilatory assay, Western blotting, quantitative immunohistochemistry, PKG activity assay, pharmacological PKG inhibitors (Rp-8-Br-PET-cGMPS, KT-5823)\",\n      \"journal\": \"American Journal of Physiology: Lung Cellular and Molecular Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional and protein quantification in tissue fractions with pharmacological validation; single lab\",\n      \"pmids\": [\"12765880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PRKG1 (PKG1) lies downstream of sGC/cGMP signaling and upstream of PINK1 activation. Vericiguat (sGC stimulator) upregulates PRKG1, which activates PINK1 to inhibit mitochondrial dysfunction and mtDNA cytoplasmic leakage, subsequently suppressing the STING/IRF3 inflammatory pathway in doxorubicin-induced cardiotoxicity.\",\n      \"method\": \"Adeno-associated virus-mediated cardiac PRKG1 manipulation (overexpression/silencing), RNA sequencing pathway analysis, Western blotting for PINK1/STING/IRF3, cardiomyocyte mitochondrial function assays, mouse I/R model\",\n      \"journal\": \"Translational Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with pathway marker readouts; single lab, multiple methods\",\n      \"pmids\": [\"39059761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PKG (PRKG1) induces mitochondrial biogenesis in renal proximal tubule cells via a pathway requiring p38 MAPK downstream of PKG. Pharmacological PKG activation (via sGC stimulation) and specific inhibitor studies establish the sequence: sGC → cGMP → PKG → p38 → PGC-1α nuclear localization and phosphorylation.\",\n      \"method\": \"Pharmacological inhibitors of PKG and p38 in renal proximal tubule cells, in vivo l-skepinone (p38 inhibitor) treatment in mice, nuclear fractionation for phospho-PGC-1α, mitochondrial biogenesis markers\",\n      \"journal\": \"American Journal of Physiology: Renal Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established with multiple pharmacological probes in vitro and in vivo; single lab\",\n      \"pmids\": [\"31841384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PKG activity is required for heparin-induced inhibition of vascular smooth muscle cell proliferation. Chemical inhibition of PKG (Rp-8-pCPT-cGMS) and siRNA knockdown of PKG both eliminate heparin effects on BrdU incorporation, ERK activity, Elk-1 phosphorylation, and MKP-1 synthesis. Heparin transiently increases intracellular cGMP, placing PKG downstream of heparin cell-surface receptor engagement.\",\n      \"method\": \"Chemical PKG inhibitor, PKG siRNA knockdown, BrdU incorporation, ERK/Elk-1 Western blotting, MKP-1 immunoblotting, cGMP ELISA in vascular smooth muscle cells\",\n      \"journal\": \"Journal of Cellular Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA plus pharmacological inhibition with multiple downstream substrate readouts; single lab\",\n      \"pmids\": [\"24911927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MASTL-ENSA/ARPP19-PP2A cell cycle checkpoint pathway is present and functional in anucleate human platelets. PKG (activated by cGMP-elevating agents including NO donors and riociguat) phosphorylates ENSA at S109 and ARPP19 at S104, as validated with recombinant PKG and phospho-mutants. These PKG phosphorylation sites are distinct from the MASTL-targeted S67/S62 sites.\",\n      \"method\": \"Proteomics in human platelets, recombinant MASTL/PKA/PKG kinase assays with recombinant ENSA/ARPP19 and phospho-mutants, pharmacological activation (iloprost, NO donors, riociguat, okadaic acid)\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with recombinant PKG and defined substrates, validated in intact human platelets; single lab\",\n      \"pmids\": [\"32085646\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PRKG1 encodes cGMP-dependent protein kinase type I (PKG-1), a homodimeric serine/threonine kinase whose N-terminal leucine zipper dimerizes and targets the enzyme via G-kinase-anchoring proteins (including a redox-active C42 disulfide that stabilizes the dimer and localizes the kinase to distinct microdomains); cGMP binding to the high-affinity cyclic nucleotide-binding domain B induces an active dimeric conformation that is structurally distinct from PKA, while cAMP acts as a partial agonist by stabilizing a third partially autoinhibited state; activated PKG-1 phosphorylates a broad substrate network including TSC2 (suppressing stress-stimulated mTORC1), IRAG (reducing ER Ca2+ release via IP3R-I), VASP (modulating cytoskeletal and channel function), and ENSA/ARPP19 (regulating PP2A), thereby controlling vascular smooth muscle relaxation, cardiac hypertrophy, autophagy, platelet inhibition, and inner-ear hair cell survival, with gain-of-function mutations (e.g., p.Arg177Gln) causing constitutive kinase activity and hereditary thoracic aortic aneurysm/dissection.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PRKG1 encodes cGMP-dependent protein kinase type I (PKG-1), a serine/threonine kinase that transduces nitric oxide/cGMP signaling into control of vascular smooth-muscle tone, cardiac remodeling, and cell survival [#0, #1, #9]. The single-copy gene generates Iα and Iβ isoforms through alternative first exons that differ only in their N-terminal regions [#2]. Activation is governed by cyclic nucleotide binding to the regulatory domain: crystallography and SAXS show two regulatory domains forming a symmetric dimer in which cGMP bound at the high-affinity B pockets provides critical inter-subunit contacts to drive an active conformation structurally distinct from PKA [#3], while NMR analysis establishes that cGMP acts through two-state conformational selection and cAMP is only a partial agonist that samples a third, partially autoinhibited state [#4]. The N-terminal leucine zipper additionally carries C42, which forms an interchain disulfide upon oxidation that stabilizes the dimer [#5] and, in stressed cardiomyocytes, drives PDE5 activation and PKG1α–PDE5 colocalization that underlies the antihypertrophic benefit of PDE5 inhibition [#6]. Once active, PKG-1 phosphorylates a broad substrate network: it phosphorylates TSC2 (S1364/S1365) to activate its RHEB-GAP function, suppressing stress-stimulated mTORC1 and thereby limiting cardiac hypertrophy and promoting autophagy [#1]; PKG1β forms a trimeric complex with IRAG and IP3 receptor type I at the ER, where phosphorylation of IRAG reduces IP3-mediated Ca2+ release to mediate smooth-muscle relaxation and platelet inhibition [#7]; it phosphorylates VASP at Ser239 to drive a phosphorylation-dependent VASP–TRPC4 interaction that inhibits store-operated cation entry [#8]; and it phosphorylates ENSA (S109) and ARPP19 (S104) at sites distinct from the MASTL-targeted residues in human platelets [#20]. A gain-of-function mutation, p.Arg177Gln, disrupts cGMP binding and renders PKG-1 constitutively active, causing familial thoracic aortic aneurysms and acute aortic dissections [#0].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Defining the gene architecture established that a single PRKG1 locus produces the two type I PKG isoforms, explaining how isoform-specific N-terminal functions arise from one gene.\",\n      \"evidence\": \"Gene cloning, 5'-RACE, Northern blot, and exon mapping\",\n      \"pmids\": [\"9192852\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not assign distinct functions or tissue distributions to Iα versus Iβ\", \"Regulatory elements driving the alternative first exons not characterized\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identification of VASP-Ser239 phosphorylation and a phospho-dependent VASP–TRPC4 association revealed a molecular mechanism by which PKG-1α inhibits store-operated calcium entry.\",\n      \"evidence\": \"Ca2+ imaging, co-IP, immunocytochemistry, and PKG-1α inhibitor (DT-3) in glomerular mesangial cells\",\n      \"pmids\": [\"17913834\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct phosphorylation by PKG-1α not reconstituted in vitro\", \"How pVASP physically inhibits TRPC4 gating unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Linking the cGMP/PKG pathway to mitochondrial KATP channel opening and Zn2+/ERK signaling connected PKG activity to cardioprotection against oxidative stress.\",\n      \"evidence\": \"Fluorescence imaging of Zn2+ and mitochondrial membrane potential with pharmacological probes in adult rat cardiomyocytes\",\n      \"pmids\": [\"17570352\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct PKG substrate mediating Zn2+ release not identified\", \"Relies on pharmacological inhibitors rather than genetic loss-of-function\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that PKG inhibits TCF/β-catenin transcription via CTNNB1 repression and FOXO4-dependent sequestration extended PKG signaling into tumor-relevant transcriptional control.\",\n      \"evidence\": \"Luciferase reporters, co-IP, FOXO4 siRNA, and nuclear fractionation in colon cancer cells\",\n      \"pmids\": [\"20348951\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct PKG substrate in the JNK/FOXO4 axis not defined\", \"Single cell-type context\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Isoform-specific assembly of a PKG1β–IRAG–IP3R-I complex explained how cGMP suppresses ER calcium release for smooth-muscle relaxation and platelet inhibition.\",\n      \"evidence\": \"Co-IP, isoform-specific interaction mapping, and phosphorylation/functional assays in smooth muscle and platelets\",\n      \"pmids\": [\"21666108\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Summarized from prior reports rather than a single primary dataset\", \"Structural basis of the trimeric complex unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Prkg1 knockout established an endogenous cGMP-PKG protective pathway in cochlear hair cells and neurons, broadening PKG function beyond the vasculature.\",\n      \"evidence\": \"Prkg1 knockout mice, auditory brainstem responses, PDE5-inhibitor rescue, and PAR immunostaining\",\n      \"pmids\": [\"22270721\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PKG substrates mediating hair-cell survival not identified\", \"Mechanistic link between PKG and PAR upregulation unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"A constitutively activating p.Arg177Gln mutation directly linked PRKG1 to a Mendelian aortic disease, showing that unregulated kinase activity disrupts smooth-muscle contraction.\",\n      \"evidence\": \"Exome/Sanger sequencing, kinase and myosin light-chain phosphorylation assays in patient fibroblasts, LOD analysis across families\",\n      \"pmids\": [\"23910461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full substrate consequences of constitutive activity in vascular cells not mapped\", \"Tissue-specificity of the aortic phenotype not mechanistically explained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Multiple studies placed PKG within distinct upstream and downstream signaling contexts—heparin antiproliferative signaling, hypoxic miR-20a repression, and PVAT anticontractile function—defining its position in vascular regulation.\",\n      \"evidence\": \"PKG siRNA/inhibitors with ERK-Elk-1-MKP-1 readouts; miR-20a coding-region target mapping; PKG−/− mouse myography (years 2014, 2019)\",\n      \"pmids\": [\"24911927\", \"25447536\", \"24095868\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct PKG substrates in each context largely undefined\", \"Cross-talk among these vascular roles not integrated\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Biophysical and structural work resolved the activation mechanism: cGMP-driven two-state selection versus cAMP partial agonism, leucine-zipper C42 disulfide dimer stabilization, and a downstream CSE/H2S cardioprotective output.\",\n      \"evidence\": \"NMR of CNB-B; crystal structures of WT and C42L leucine zipper; adenoviral PKGIα/K390A with CSE inhibition in I/R models\",\n      \"pmids\": [\"26370085\", \"26132214\", \"26036467\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CNB-B conformational states couple to full-length kinase activation in vivo not shown\", \"Direct PKG substrate inducing CSE not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The cGMP-bound regulatory-domain crystal structure defined the active dimer interface and showed PKG's active conformation is distinct from PKA, providing a structural framework for cyclic-nucleotide selectivity.\",\n      \"evidence\": \"X-ray crystallography at 2.5 Å, SAXS, and site-directed mutagenesis\",\n      \"pmids\": [\"27066748\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length holoenzyme structure not solved\", \"Conformational transition to the catalytic domain not visualized\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Redox-dead C42S knock-in mice demonstrated that C42 oxidation governs PKG1α-PDE5 colocalization and the therapeutic response to PDE5 inhibition, tying the structural disulfide to a subcellular signaling microdomain.\",\n      \"evidence\": \"PKG1αC42S knock-in mice, transaortic constriction, activity assays, immunofluorescence colocalization, pharmacological dissection\",\n      \"pmids\": [\"29545395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which oxidized PKG1α activates PDE5 not defined\", \"Generality beyond cardiac stress unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of TSC2-S1364/S1365 as a direct PKG substrate, validated by phospho-mutant knock-in mice, established PKG's antihypertrophic and pro-autophagic action through mTORC1 suppression.\",\n      \"evidence\": \"In vitro kinase assay, phospho-specific antibodies, TSC2-S1365A/S1365E knock-in mice, transaortic constriction, echocardiography\",\n      \"pmids\": [\"30700906\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stress-specific selectivity over basal mTORC1 not fully explained\", \"Whether the same axis operates in non-cardiac tissues not established here\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"An sGC→cGMP→PKG→p38→PGC-1α epistasis defined a PKG-driven mitochondrial biogenesis program in renal proximal tubule cells.\",\n      \"evidence\": \"Pharmacological PKG and p38 inhibitors in vitro and in vivo, nuclear phospho-PGC-1α fractionation, biogenesis markers\",\n      \"pmids\": [\"31841384\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct PKG substrate upstream of p38 not identified\", \"Reliance on pharmacological epistasis without genetic PKG deletion\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Reconstitution showing PKG phosphorylates ENSA-S109 and ARPP19-S104 at sites distinct from MASTL targets revealed PKG input into the PP2A-regulatory module in anucleate platelets.\",\n      \"evidence\": \"Platelet proteomics, recombinant PKG kinase assays with ENSA/ARPP19 phospho-mutants, cGMP-elevating agents\",\n      \"pmids\": [\"32085646\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of these phosphorylations for PP2A activity in platelets not resolved\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Placing PRKG1 upstream of PINK1 and the STING/IRF3 axis connected PKG to mitochondrial quality control and inflammatory suppression in cardiotoxicity.\",\n      \"evidence\": \"AAV-mediated cardiac PRKG1 overexpression/silencing, RNA-seq, PINK1/STING/IRF3 Western blots, mitochondrial assays in mouse models\",\n      \"pmids\": [\"39059761\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct PKG substrate activating PINK1 not identified\", \"Whether the effect is kinase-dependent not isolated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How isoform-specific targeting, redox state, and the diverse substrate set are integrated into tissue-specific PKG outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No full-length holoenzyme structure capturing activation\", \"Unified substrate-selectivity logic across cardiac, vascular, renal, and platelet contexts not established\", \"Mechanism coupling C42 oxidation to specific substrate phosphorylation undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 7, 8, 20]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 8, 20]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [9, 13, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 7, 16, 17]},\n      {\"term_id\": \"R-HSA-397014\", \"supporting_discovery_ids\": [0, 13, 15]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [7, 20]}\n    ],\n    \"complexes\": [\"PKG1β–IRAG–IP3R-I ER complex\"],\n    \"partners\": [\"IRAG1\", \"ITPR1\", \"VASP\", \"TRPC4\", \"PDE5A\", \"TSC2\", \"ENSA\", \"ARPP19\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}